Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir + Ravidasvir in HCV
NCT02961426Phase 3Unknown
- Sponsor
- Drugs for Neglected Diseases initiative
- Start
- Sep 2016
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of ravidasvir in hepatitis C (HCV), sponsored by Drugs for Neglected Diseases initiative. Status: unknown.
02
Drugs
ravidasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02961426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02961426.